Vontobel Holding Ltd. Bridge Bio Pharma, Inc. Transaction History

Vontobel Holding Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$27.35 - $40.45 $16,273 - $24,067	-595 Reduced 1.93%	30,216 $934,000
Q4 2023 Jun 03, 2024	SELL	$24.02 - $43.89 $853,814 - $1.56 Million	-35,546 Reduced 53.57%	30,811 $1.24 Million
Q4 2023 Jan 29, 2024	SELL	$24.02 - $43.89 $853,814 - $1.56 Million	-35,546 Reduced 53.57%	30,811 $1.24 Million
Q3 2023 Jun 03, 2024	SELL	$16.89 - $35.01 $20,301 - $42,082	-1,202 Reduced 1.78%	66,357 $1.75 Million
Q3 2023 Oct 10, 2023	SELL	$16.89 - $35.01 $20,301 - $42,082	-1,202 Reduced 1.78%	66,357 $1.75 Million
Q2 2023 Jun 03, 2024	SELL	$13.29 - $18.01 $334,389 - $453,149	-25,161 Reduced 27.14%	67,559 $1.16 Million
Q2 2023 Jul 24, 2023	SELL	$13.29 - $18.01 $334,389 - $453,149	-25,161 Reduced 27.14%	67,559 $1.16 Million
Q1 2023 Jun 03, 2024	BUY	$7.17 - $18.55 $448,153 - $1.16 Million	62,504 Added 206.86%	92,720 $1.54 Million
Q1 2023 Apr 12, 2023	SELL	$7.17 - $18.55 $92,191 - $238,515	-12,858 Reduced 12.18%	92,720 $1.54 Million
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $711,595 - $1.22 Million	105,578 New	105,578 $804,000

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.